{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:40:00Z","timestamp":1793173200120,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.vaccine.2010.06.026","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T11:05:18Z","timestamp":1277550318000},"page":"5513-5523","source":"Crossref","is-referenced-by-count":263,"title":["Glycoconjugate vaccines and immune interference: A review"],"prefix":"10.1016","volume":"28","author":[{"given":"Ron","family":"Dagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Poolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire-Anne","family":"Siegrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.06.026_bib1","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"P\u00f6llabauer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria\u2013tetanus\u2013acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2010.06.026_bib3","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1016\/j.vaccine.2007.10.013","article-title":"A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa\u2013HBV\u2013IPV and conjugate pneumococcal vaccines in infants","volume":"25","author":"Nolan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.inf.0000247070.60063.09","article-title":"Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria\u2013tetanus\u2013acellular Pertussis\u2013hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months","volume":"26","author":"Tejedor","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vaccine.2005.07.060","article-title":"Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP\/Hib vaccine","volume":"24","author":"Southern","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib6","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1016\/S0264-410X(03)00420-1","article-title":"Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa\u2013HBV\u2013IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa\u2013IPV\/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age","volume":"21","author":"Ar\u00edstegui","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000227725.61495.c4","article-title":"Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria\u2013tetanus\u2013acellular pertussis\u2013hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine","volume":"25","author":"Tejedor","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CVI.00377-06","article-title":"Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae\u2013Neisseria meningitidis serogroup C conjugate vaccine","volume":"14","author":"Schmitt","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004310050797","article-title":"Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria\u2013tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations","volume":"157","author":"Schmitt","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2010.06.026_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00006454-199403000-00005","article-title":"Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children","volume":"13","author":"Pichichero","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib11","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/0264-410X(95)00137-P","article-title":"Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States","volume":"13","author":"Bernstein","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib12","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria\u2013tetanus\u2013pertussis containing acellular pertussis","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.06.026_bib13","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0264-410X(00)00517-X","article-title":"Clinical relevance of lower Hib response in DTPa-based combination vaccines","volume":"19","author":"Poolman","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3476(88)80684-X","article-title":"Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children","volume":"112","author":"Claesson","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2010.06.026_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.iy.01.040183.003141","article-title":"Epitope-specific regulation","volume":"1","author":"Herzenberg","year":"1983","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib16","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.4049\/jimmunol.145.8.2397","article-title":"Clonal anergy of memory B-cells in epitope-specific regulation","volume":"145","author":"Galelli","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib17","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.135.4.2319","article-title":"Carrier-induced epitopic suppression, a major issue for future synthetic vaccines","volume":"135","author":"Schutze","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib18","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.142.8.2635","article-title":"Carrier-induced epitopic suppression is initiated through clonal dominance","volume":"142","author":"Schutze","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0008-8749(86)90297-2","article-title":"Epitope-specific regulation in Ir gene systems. I. Conditions for the induction of epitope-specific suppressors to poly(Glu60Ala30Tyr10)","volume":"98","author":"Sun","year":"1986","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(89)92033-3","article-title":"Effect of priming with carrier on response to conjugate vaccine","volume":"334","author":"Di John","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.06.026_bib21","first-page":"551","article-title":"Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum","volume":"64","author":"Etlinger","year":"1988","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2010.06.026_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/intimm\/2.2.151","article-title":"Bypass by an alternate \u2018carrier\u2019 of acquired unresponsiveness to hCG upon repeated immunization with tetanus-conjugated vaccine","volume":"2","author":"Gaur","year":"1990","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1995.tb44436.x","article-title":"Potential alterations in immunogenicity by combining or simultaneously administering vaccine components","volume":"754","author":"Insel","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2010.06.026_bib24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4049\/jimmunol.145.5.1343","article-title":"The in vivo elimination of CD4+ T-cells prevents the induction but not the expression of carrier-induced epitopic suppression","volume":"145","author":"Leclerc","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib25","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/IAI.59.10.3504-3510.1991","article-title":"Effect of carrier priming on immunogenicity of saccharide\u2013protein conjugate vaccines","volume":"59","author":"Peeters","year":"1991","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2010.06.026_bib26","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2010.06.026_bib27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/sim.3095","article-title":"Construction of confidence limits about effect measures: a general approach","volume":"27","author":"Zou","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2010.06.026_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa\u2013Hib: impact of IPV and coadministration of CRM197 conjugates","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.06.026_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpeds.2008.04.032","article-title":"Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization","volume":"153","author":"Siegrist","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2010.06.026_bib30","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.vaccine.2005.11.021","article-title":"Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP. IPV\/PRP-T Hib and hepatitis B vaccines in infants 2\u20137 months of age","volume":"24","author":"Scheifele","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4161\/hv.5.1.6520","article-title":"Simultaneous vaccination with Prevenar and multicomponent vaccines for children: interference or no interference?","volume":"5","author":"Boot","year":"2009","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2010.06.026_bib32","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.vaccine.2007.11.096","article-title":"Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa\u2013IPV\u2013HBV\u2013Hib combination vaccine in healthy infants","volume":"26","author":"Olivier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2008.03.011","article-title":"Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine","volume":"153","author":"Halasa","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2010.06.026_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jpeds.2007.09.034","article-title":"Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants","volume":"152","author":"Knuf","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2010.06.026_bib35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.273.11.849","article-title":"Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants","volume":"273","author":"Anderson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.06.026_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide\u2013protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.06.026_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00006454-199306000-00006","article-title":"Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants","volume":"12","author":"Bulkow","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib38","series-title":"Vaccines","first-page":"229","article-title":"Haemophilus influenzae vaccine","author":"Wenger","year":"2004"},{"key":"10.1016\/j.vaccine.2010.06.026_bib39","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4049\/jimmunol.172.4.2431","article-title":"Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity","volume":"172","author":"Latz","year":"2004","journal-title":"J Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2010.06.026_bib40","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/0264-410X(93)90160-Y","article-title":"Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines","volume":"11","author":"Granoff","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/00365540110026502","article-title":"Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults","volume":"33","author":"Shelly","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.06.026_bib42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jama.272.14.1116","article-title":"Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants","volume":"272","author":"Granoff","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.06.026_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/IAI.62.1.9-14.1994","article-title":"Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine","volume":"62","author":"Barington","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.06.026_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1203\/00006450-199101000-00003","article-title":"Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys","volume":"29","author":"Vella","year":"1991","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2010.06.026_bib45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0022-3476(95)70545-7","article-title":"Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines","volume":"126","author":"Lieberman","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2010.06.026_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(95)70546-5","article-title":"Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines","volume":"126","author":"Greenberg","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2010.06.026_bib47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.06.026_bib48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.inf.0000126297.28952.f8","article-title":"Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants","volume":"23","author":"Rennels","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.06.026_bib50","series-title":"47th annual ICAAC","article-title":"Immunogenicity of 1 dose of a candidate meningococcal tetravalent tetanus toxoid conjugate (MenACWY-TT) vaccine in 12\u201314 month and 3\u20135 years olds","author":"Prieler","year":"2006"},{"key":"10.1016\/j.vaccine.2010.06.026_bib51","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00006454-199405000-00007","article-title":"A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics","volume":"13","author":"Steinhoff","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib52","series-title":"35th annual ICAAC","article-title":"Safety and immunogenicity of a pentavalent pneumococcal conjugate vaccine (PPCV) in healthy toddlers","author":"Chiu","year":"1995"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2010.06.026_bib53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1203\/00006450-199604001-01104","article-title":"Immunogenicity and safety of 7 valent pneumococcal CRM197","volume":"39","author":"Rennels","year":"1996","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2010.06.026_bib54","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jama.293.14.1751","article-title":"Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial","volume":"293","author":"Buttery","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.06.026_bib55","series-title":"48th annual ICAAC","article-title":"Safety and immunologic non-inferiority of 13-valent pneumococcal conjugate vaccine compared to 7-valent pneumococcal conjugate vaccine given as a 4-dose series with routine vaccines in healthy infants and toddlers","author":"Kieninger","year":"2008"},{"key":"10.1016\/j.vaccine.2010.06.026_bib56","series-title":"48th annual ICAAC","article-title":"Immunogenicity of DTaP-IPV-Hib and MenC vaccines in the UK when administered with a 13-valent pneumococcal conjugate vaccine","author":"Klinger","year":"2008"},{"key":"10.1016\/j.vaccine.2010.06.026_bib57","series-title":"48th annual ICAAC","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccination to healthy infants in France","author":"Grimprel","year":"2008"},{"key":"10.1016\/j.vaccine.2010.06.026_bib58","series-title":"34th annual ICAAC","article-title":"Immunologic response of 12\u201318 months old children to licensed pneumococcal polysaccharide vaccine (PS) primed with Streptococcus pneumoniae 19F conjugate vaccine (CV)","author":"Kennedy","year":"1994"},{"key":"10.1016\/j.vaccine.2010.06.026_bib59","series-title":"34th annual ICAAC","article-title":"Serum antibody response to a tetravalent pneumococcal tetanus toxoid conjugate vaccine in adult volunteers","author":"Portier","year":"1994"},{"key":"10.1016\/j.vaccine.2010.06.026_bib60","series-title":"36th annual ICAAC","article-title":"Immunogenicity of octavalent Pneumococcal (Pnc) Conjugate Vaccines (PncD, PncT)","author":"Ahman","year":"1996"},{"key":"10.1016\/j.vaccine.2010.06.026_bib61","series-title":"37th annual ICAAC","article-title":"Functional activity of antibodies elicited by octavalent pneumococcal polysaccharide conjugate vaccines PncT and PncD","author":"Jonsdottir","year":"1997"},{"key":"10.1016\/j.vaccine.2010.06.026_bib62","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.06.026_bib63","first-page":"184A","article-title":"Immunogenicity of type 14 conjugate vaccine in infants","volume":"35","author":"Keyserling","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2010.06.026_bib64","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/infdis\/172.5.1273","article-title":"Pneumococcal polysaccharide meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children","volume":"172","author":"K\u00e4yhty","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.06.026_bib65","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.06.026_bib66","series-title":"19th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID)","article-title":"A randomized, placebo-controlled, dose-range study to evaluate the immunogenicity of a tetravalent pneumococcal protein D conjugate vaccine in infants, and boostability by plain polysaccharide","author":"Arguedas","year":"2001"},{"key":"10.1016\/j.vaccine.2010.06.026_bib67","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.06.026_bib68","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib69","series-title":"Vaccines 1994. Modern approaches to new vaccines including prevention of AIDS","article-title":"Pneumococcal conjugate vaccines","author":"Eby","year":"1994"},{"key":"10.1016\/j.vaccine.2010.06.026_bib70","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00006454-199602000-00009","article-title":"Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well tolerated and able to induce an antibody response in infants","volume":"15","author":"\u00c5hman","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/IAI.65.1.242-247.1997","article-title":"Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults","volume":"65","author":"Shelly","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.06.026_bib72","series-title":"35th annual ICAAC","article-title":"Immunogenicity of S. pneumoniae oligo- and polygo-saccharide-CRM 197 conjugate vaccines in healthy US infants","author":"Daum","year":"1995"},{"key":"10.1016\/j.vaccine.2010.06.026_bib73","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00006454-199803000-00008","article-title":"Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory","volume":"17","author":"\u00c5hman","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib74","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/S0264-410X(99)00048-1","article-title":"Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid","volume":"17","author":"\u00c5hman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib75","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.06.026_bib76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/mdr.1995.1.49","article-title":"Pneumococcal conjugate vaccines: review and update","volume":"1","author":"Klein","year":"1995","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.vaccine.2010.06.026_bib77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00006454-199003000-00007","article-title":"Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia","volume":"9","author":"Sarnaik","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib78","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/IAI.60.9.3528-3532.1992","article-title":"Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin","volume":"60","author":"Schneerson","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.06.026_bib79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/1359-6446(96)10032-5","article-title":"Capsular polysaccharide\u2013protein conjugate vaccines","volume":"1","author":"Sood","year":"1996","journal-title":"Drug Disc Today"},{"key":"10.1016\/j.vaccine.2010.06.026_bib80","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0008-8749(87)90264-4","article-title":"Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide","volume":"107","author":"Vogel","year":"1987","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib81","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00006454-200206000-00013","article-title":"Immune response to octavalent diphtheria- and tetanus-conjugated pneumococcal vaccines is serotype- and carrier-specific: the choice for a mixed carrier vaccine","volume":"21","author":"Sigurdardottir","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib82","series-title":"27th annual meeting of the European Society for Paedatric Infectious Disease (ESPID)","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine manufactured with and without polysorbate 80 in healthy infants given a 2, 3, 4 and 12 months of age","author":"Gadzinowski","year":"2009"},{"key":"10.1016\/j.vaccine.2010.06.026_bib83","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00006454-200009000-00009","article-title":"Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type B conjugate vaccine in United Kingdom infants","volume":"19","author":"Choo","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib84","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom","volume":"16","author":"Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib85","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/CVI.00315-09","article-title":"The immunogenicity of a heptavalent conjugate pneumococcal vaccine concurrently administered with a combination DTaP\/IPV\/Hib vaccine and a meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"17","author":"Moss","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.06.026_bib86","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0264-410X(03)00013-6","article-title":"Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants","volume":"21","author":"Zangwill","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib87","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00006454-199711000-00010","article-title":"Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/biol.1994.1062","article-title":"Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines","volume":"22","author":"K\u00e4yhty","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2010.06.026_bib89","series-title":"6th international symposium on pneumococci and pneumococcal diseases","article-title":"Immunogenicity of CRM-conjugated 7-valent pneumococcal conjugate vaccine (PCV7) administered at 2-dose (4 and 6m) or 3-dose primary regimen (2, 4 and 6m) with a booster at 12m","author":"Givon-Lavi","year":"2008"},{"key":"10.1016\/j.vaccine.2010.06.026_bib90","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.vaccine.2006.12.008","article-title":"ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media","volume":"25","author":"Schuerman","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib91","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.vaccine.2009.03.017","article-title":"Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics","volume":"27","author":"Poolman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib92","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.06.026_bib93","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/j.vaccine.2005.01.087","article-title":"Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age","volume":"23","author":"Tichmann","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.026_bib94","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/01.inf.0000145427.19167.35","article-title":"Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria\u2013tetanus\u2013acellular pertussis\u2013hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine","volume":"23","author":"Tejedor","year":"2004","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T19:27:05Z","timestamp":1685647625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10008261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":94,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0264410X10008261"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}